Yahoo Web Search

Search results

1. • 

     Invest with Confidence: Intrinsic Value Unveiled of AbbVie Inc

     GuruFocus.com via Yahoo Finance· 1 hour ago

     In this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and...

2. • Abbvie Inc [ABBV] Stock sold by Insider Donoghoe Nicholas for $3.72 million – Knox Daily

     Knox Daily· 12 hours ago

     In a filing, Abbvie Inc revealed its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million on Mar 20 ’24. In the deal valued ...

3. • 

     Humira biosimilar scripts take off

     Axios· 3 hours ago

     Prescribing of biosimilars for AbbVie's blockbuster rheumatoid arthritis drug Humira surged just over a week following a change in drug coverage by CVS...

4. • 

     AbbVie Inc's Dividend Analysis

     GuruFocus.com via Yahoo Finance· 5 days ago

     AbbVie Inc (NYSE:ABBV) recently announced a dividend of $1.55 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-12. As...

5. • AbbVie Inc. (NYSE:ABBV) Receives $177.43 Average PT from Analysts

     ETF DAILY NEWS· 1 day ago

     AbbVie Inc. (NYSE:ABBV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the stock, Marketbeat ...

6. • 

     Is AbbVie a Millionaire Maker?

     Motley Fool via Yahoo Finance· 2 days ago

     Big pharma stocks like AbbVie (NYSE: ABBV) usually aren't high on the list that investors look to for opportunities that could make them into...

7. • AbbVie's Options Frenzy: What You Need to Know - AbbVie (NYSE:ABBV)

     Benzinga· 20 hours ago

     Loading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie . Looking at options history for AbbVie ABBV ...

8. • 

     AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors

     Zacks via Yahoo Finance· 5 days ago

     AbbVie (ABBV) closed the latest trading day at $167.52, indicating a -0.89% change from the previous...

9. • 

     AbbVie retains Humira market despite copycats (NYSE:ABBV)

     Seeking Alpha· 3 days ago

     Despite the entry of discounted biosimilars, AbbVie (ABBV) has maintained 96% market share for its...

10. • AbbVie (NYSE:ABBV) Trading Down 0.6%

      ETF DAILY NEWS· 3 days ago

      AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price was down 0.6% during mid-day trading on Thursday . The company traded as low as $167.29 and last traded at $167.99.